Clinical Trials Browser

Phase 1/2 × gedatolisib × Breast × Clear all

NCT03911973 2024-06-07

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms

NCT03400254 2020-04-28

GLACIER

Phase 1/2 Withdrawn

Breast Neoplasms